New Jersey’s proposed addition of five conditions that can be treated with medical marijuana could expand the program’s patient pool and, in turn, lead to increased sales for the handful of dispensaries in the state.
The state’s Medicinal Marijuana Review Panel gave final approval to the additional conditions this week, Patch.com reported, but that number fell far short of the 43 conditions the committee had recommended.
Here’s what you need to know:
- The panel proposed adding anxiety, migraine, Tourette’s syndrome, chronic pain related to musculoskeletal disorders, and chronic pain related to internal organs.
- The state’s health commissioner – who was appointed by the notoriously anti-cannabis Gov. Chris Christie – has up to 180 days to decide whether to approve the extra conditions.
- New Jersey’s MMJ program currently has 12,500-plus registered patients.
- State law allows for only six licensed dispensaries – though only five are currently operational – but the health department reviews the program every two years to decide whether more should be approved.